| Year |
Citation |
Score |
| 2023 |
Romanazzi T, Zanella D, Bhatt M, Di Iacovo A, Galli A, Bossi E. Bile acid interactions with neurotransmitter transporters. Frontiers in Cellular Neuroscience. 17: 1161930. PMID 37180953 DOI: 10.3389/fncel.2023.1161930 |
0.381 |
|
| 2023 |
Shekar A, Mabry SJ, Cheng MH, Aguilar JI, Patel S, Zanella D, Saleeby DP, Zhu Y, Romanazzi T, Ulery-Reynolds P, Bahar I, Carter AM, Matthies HJG, Galli A. Syntaxin 1 Ser phosphorylation is required for nonvesicular dopamine release. Science Advances. 9: eadd8417. PMID 36630507 DOI: 10.1126/sciadv.add8417 |
0.449 |
|
| 2021 |
Romanazzi T, Zanella D, Cheng MH, Smith B, Carter AM, Galli A, Bahar I, Bossi E. Bile Acids Gate Dopamine Transporter Mediated Currents. Frontiers in Chemistry. 9: 753990. PMID 34957043 DOI: 10.3389/fchem.2021.753990 |
0.456 |
|
| 2021 |
Herborg F, Jensen KL, Tolstoy S, Arends NV, Posselt LP, Shekar A, Aguilar JI, Lund VK, Erreger K, Rickhag M, Lycas MD, Lonsdale MN, Rahbek-Clemmensen T, Sørensen AT, Newman AH, ... ... Galli A, et al. Dominant-negative actions of a dopamine transporter variant identified in patients with parkinsonism and neuropsychiatric disease. Jci Insight. PMID 34375312 DOI: 10.1172/jci.insight.151496 |
0.784 |
|
| 2021 |
Aguilar JI, Cheng MH, Font J, Schwartz AC, Ledwitch K, Duran A, Mabry SJ, Belovich AN, Zhu Y, Carter AM, Shi L, Kurian MA, Fenollar-Ferrer C, Meiler J, Ryan RM, ... ... Galli A, et al. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. Elife. 10. PMID 34002696 DOI: 10.7554/eLife.68039 |
0.302 |
|
| 2020 |
Jensen ME, Galli A, Thomsen M, Jensen KL, Thomsen GK, Klausen MK, Vilsbøll T, Christensen MB, Holst JJ, Owens A, Robertson S, Daws L, Zanella D, Gether U, Knudsen GM, et al. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent. Neurochemistry International. 104772. PMID 32464226 DOI: 10.1016/J.Neuint.2020.104772 |
0.708 |
|
| 2020 |
Graham DL, Durai HH, Trammell T, Noble BL, Mortlock DP, Galli A, Stanwood GD. A novel mouse model of glucagon-like peptide-1 receptor expression: a look at the brain. The Journal of Comparative Neurology. PMID 32170734 DOI: 10.1002/Cne.24905 |
0.311 |
|
| 2019 |
Belovich AN, Aguilar JI, Mabry SJ, Cheng MH, Zanella D, Hamilton PJ, Stanislowski DJ, Shekar A, Foster JD, Bahar I, Matthies HJG, Galli A. A network of phosphatidylinositol (4,5)-bisphosphate (PIP) binding sites on the dopamine transporter regulates amphetamine behavior in Drosophila Melanogaster. Molecular Psychiatry. PMID 31796894 DOI: 10.1038/S41380-019-0620-0 |
0.715 |
|
| 2019 |
DiCarlo GE, Aguilar JI, Matthies HJ, Harrison FE, Bundschuh KE, West A, Hashemi P, Herborg F, Rickhag M, Chen H, Gether U, Wallace MT, Galli A. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors. The Journal of Clinical Investigation. 130. PMID 31094705 DOI: 10.1172/Jci127411 |
0.572 |
|
| 2019 |
Campbell NG, Shekar A, Aguilar JI, Peng D, Navratna V, Yang D, Morley AN, Duran AM, Galli G, O'Grady B, Ramachandran R, Sutcliffe JS, Sitte HH, Erreger K, Meiler J, ... ... Galli A, et al. Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in . Proceedings of the National Academy of Sciences of the United States of America. PMID 30755521 DOI: 10.1073/Pnas.1816247116 |
0.789 |
|
| 2018 |
Reddy IA, Smith NK, Erreger K, Ghose D, Saunders C, Foster DJ, Turner B, Poe A, Albaugh VL, McGuinness O, Hackett TA, Grueter BA, Abumrad NN, Flynn CR, Galli A. Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward. Plos Biology. 16: e2006682. PMID 30048457 DOI: 10.1371/Journal.Pbio.2006682 |
0.735 |
|
| 2018 |
Barry RL, Byun NE, Williams JM, Siuta MA, Tantawy MN, Speed NK, Saunders C, Galli A, Niswender KD, Avison MJ. Brief exposure to obesogenic diet disrupts brain dopamine networks. Plos One. 13: e0191299. PMID 29698491 DOI: 10.1371/Journal.Pone.0191299 |
0.814 |
|
| 2018 |
Galli A. 27.4 STRUCTURAL, FUNCTIONAL, AND BEHAVIORAL INSIGHTS OF DOPAMINE DYSFUNCTION REVEALED BY A DELETION IN SLC6A3 Schizophrenia Bulletin. 44: S45-S46. DOI: 10.1093/Schbul/Sby014.114 |
0.539 |
|
| 2017 |
Garcia-Olivares J, Baust T, Harris S, Hamilton P, Galli A, Amara SG, Torres GE. Gβγ subunit activation promotes dopamine efflux through the dopamine transporter. Molecular Psychiatry. PMID 28894302 DOI: 10.1038/Mp.2017.176 |
0.736 |
|
| 2017 |
Shekar A, Aguilar JI, Galli G, Cozzi NV, Brandt SD, Ruoho AE, Baumann MH, Matthies HJ, Galli A. Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter. Journal of Chemical Neuroanatomy. PMID 28163218 DOI: 10.1016/J.Jchemneu.2017.01.004 |
0.587 |
|
| 2016 |
Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, ... ... Galli A, et al. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Translational Psychiatry. 6: e809. PMID 27187231 DOI: 10.1038/Tp.2016.86 |
0.771 |
|
| 2015 |
Saunders C, Galli A. Insights in how amphetamine ROCKs (Rho-associated containing kinase) membrane protein trafficking. Proceedings of the National Academy of Sciences of the United States of America. PMID 26607447 DOI: 10.1073/Pnas.1520960112 |
0.542 |
|
| 2015 |
Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiology & Behavior. 149: 262-8. PMID 26072178 DOI: 10.1016/J.Physbeh.2015.06.013 |
0.426 |
|
| 2015 |
Dadalko OI, Siuta M, Poe A, Erreger K, Matthies HJ, Niswender K, Galli A. mTORC2/Rictor Signaling Disrupts Dopamine-Dependent Behaviors via Defects in Striatal Dopamine Neurotransmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 8843-54. PMID 26063917 DOI: 10.1523/Jneurosci.0887-15.2015 |
0.788 |
|
| 2015 |
Cartier E, Hamilton PJ, Belovich AN, Shekar A, Campbell NG, Saunders C, Andreassen TF, Gether U, Veenstra-Vanderweele J, Sutcliffe JS, Ulery-Reynolds PG, Erreger K, Matthies HJ, Galli A. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors. Ebiomedicine. 2: 135-146. PMID 25774383 DOI: 10.1016/J.Ebiom.2015.01.007 |
0.857 |
|
| 2015 |
Hamilton PJ, Shekar A, Belovich AN, Christianson NB, Campbell NG, Sutcliffe JS, Galli A, Matthies HJ, Erreger K. Zn(2+) reverses functional deficits in a de novo dopamine transporter variant associated with autism spectrum disorder. Molecular Autism. 6: 8. PMID 25741436 DOI: 10.1186/S13229-015-0002-7 |
0.804 |
|
| 2015 |
Bellot M, Galandrin S, Boularan C, Matthies HJ, Despas F, Denis C, Javitch J, Mazères S, Sanni SJ, Pons V, Seguelas MH, Hansen JL, Pathak A, Galli A, Sénard JM, et al. Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling. Nature Chemical Biology. 11: 271-9. PMID 25706338 DOI: 10.1038/Nchembio.1766 |
0.312 |
|
| 2014 |
Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli A. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Translational Psychiatry. 4: e464. PMID 25313507 DOI: 10.1038/Tp.2014.90 |
0.841 |
|
| 2014 |
Reddy IA, Wasserman DH, Ayala JE, Hasty AH, Abumrad NN, Galli A. Striatal dopamine homeostasis is altered in mice following Roux-en-Y gastric bypass surgery. Acs Chemical Neuroscience. 5: 943-51. PMID 25068716 DOI: 10.1021/Cn500137D |
0.429 |
|
| 2014 |
Hansen FH, Skjørringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K, Andreassen TF, Holy M, Hamilton PJ, Neergheen V, Karlsborg M, Newman AH, Pope S, Heales SJ, Friberg L, ... ... Galli A, et al. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. The Journal of Clinical Investigation. 124: 3107-20. PMID 24911152 DOI: 10.1172/Jci73778 |
0.818 |
|
| 2014 |
Hamilton PJ, Belovich AN, Khelashvili G, Saunders C, Erreger K, Javitch JA, Sitte HH, Weinstein H, Matthies HJ, Galli A. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein. Nature Chemical Biology. 10: 582-9. PMID 24880859 DOI: 10.1038/Nchembio.1545 |
0.831 |
|
| 2014 |
Reddy IA, Stanwood GD, Galli A. Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward. Neurochemistry International. 73: 49-55. PMID 24140429 DOI: 10.1016/J.Neuint.2013.10.003 |
0.342 |
|
| 2014 |
Saunders C, Siuta M, Robertson SD, Davis AR, Sauer J, Matthies HJ, Gresch PJ, Airey DC, Lindsley CW, Schetz JA, Niswender KD, Veenstra-Vanderweele JM, Galli A. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function. Neurochemistry International. 73: 113-21. PMID 24090638 DOI: 10.1016/J.Neuint.2013.09.015 |
0.341 |
|
| 2013 |
Hamilton PJ, Campbell NG, Sharma S, Erreger K, Hansen FH, Saunders C, Belovich AN, Sahai MA, Cook EH, Gether U, McHaourab HS, Matthies HJ, Sutcliffe JS, Galli A. Drosophila melanogaster: a novel animal model for the behavioral characterization of autism-associated mutations in the dopamine transporter gene. Molecular Psychiatry. 18: 1235. PMID 24253181 DOI: 10.1038/Mp.2013.157 |
0.802 |
|
| 2013 |
Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, Belovich AN, Sahai MA, Cook EH, Gether U, McHaourab HS, Matthies HJ, Sutcliffe JS, Galli A. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Molecular Psychiatry. 18: 1315-23. PMID 23979605 DOI: 10.1038/mp.2013.102 |
0.838 |
|
| 2013 |
Buchmayer F, Schicker K, Steinkellner T, Geier P, Stübiger G, Hamilton PJ, Jurik A, Stockner T, Yang JW, Montgomery T, Holy M, Hofmaier T, Kudlacek O, Matthies HJ, Ecker GF, ... ... Galli A, et al. Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate. Proceedings of the National Academy of Sciences of the United States of America. 110: 11642-7. PMID 23798435 DOI: 10.1073/Pnas.1220552110 |
0.704 |
|
| 2013 |
Dixit M, Kim S, Matthews GF, Erreger K, Galli A, Cobb CE, Hustedt EJ, Beth AH. Structural arrangement of the intracellular Ca2+ binding domains of the cardiac Na+/Ca2+ exchanger (NCX1.1): effects of Ca2+ binding. The Journal of Biological Chemistry. 288: 4194-207. PMID 23233681 DOI: 10.1074/Jbc.M112.423293 |
0.676 |
|
| 2013 |
Graham DL, Erreger K, Galli A, Stanwood GD. GLP-1 analog attenuates cocaine reward. Molecular Psychiatry. 18: 961-2. PMID 23089631 DOI: 10.1038/Mp.2012.141 |
0.741 |
|
| 2012 |
Khelashvili G, Galli A, Weinstein H. Phosphatidylinositol 4,5-biphosphate (PIP(2)) lipids regulate the phosphorylation of syntaxin N-terminus by modulating both its position and local structure. Biochemistry. 51: 7685-98. PMID 22950482 DOI: 10.1021/Bi300833Z |
0.367 |
|
| 2012 |
Sakrikar D, Mazei-Robison MS, Mergy MA, Richtand NW, Han Q, Hamilton PJ, Bowton E, Galli A, Veenstra-Vanderweele J, Gill M, Blakely RD. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 5385-97. PMID 22514303 DOI: 10.1523/Jneurosci.6033-11.2012 |
0.842 |
|
| 2012 |
Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, Galli A. Exendin-4 decreases amphetamine-induced locomotor activity. Physiology & Behavior. 106: 574-8. PMID 22465309 DOI: 10.1016/J.Physbeh.2012.03.014 |
0.74 |
|
| 2012 |
Owens WA, Williams JM, Saunders C, Avison MJ, Galli A, Daws LC. Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2637-47. PMID 22357848 DOI: 10.1523/Jneurosci.3759-11.2012 |
0.481 |
|
| 2012 |
Khelashvili G, Galli A, Weinstein H. How PIP2 Lipids Regulate the Position and Phosphorylation of the Syntaxin N-Terminus Biophysical Journal. 102: 433a. DOI: 10.1016/J.Bpj.2011.11.2373 |
0.394 |
|
| 2012 |
Sitte H, Schicker K, Bulling S, Hamilton PJ, Stübiger G, Matthies HJ, Galli A, Ecker GF, Bochkov V, Boehm S, Buchmayer F. Amphetamine Actions Rely on the Availability of Phosphatidylinositol-4,5-Bisphosphate Biophysical Journal. 102: 19a. DOI: 10.1016/j.bpj.2011.11.126 |
0.545 |
|
| 2011 |
Mazei-Robison MS, Koo JW, Friedman AK, Lansink CS, Robison AJ, Vinish M, Krishnan V, Kim S, Siuta MA, Galli A, Niswender KD, Appasani R, Horvath MC, Neve RL, Worley PF, et al. Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron. 72: 977-90. PMID 22196333 DOI: 10.1016/J.Neuron.2011.10.012 |
0.565 |
|
| 2011 |
Speed N, Saunders C, Davis AR, Owens WA, Matthies HJ, Saadat S, Kennedy JP, Vaughan RA, Neve RL, Lindsley CW, Russo SJ, Daws LC, Niswender KD, Galli A. Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. Plos One. 6: e25169. PMID 21969871 DOI: 10.1371/Journal.Pone.0025169 |
0.812 |
|
| 2011 |
Daws LC, Avison MJ, Robertson SD, Niswender KD, Galli A, Saunders C. Insulin signaling and addiction. Neuropharmacology. 61: 1123-8. PMID 21420985 DOI: 10.1016/J.Neuropharm.2011.02.028 |
0.409 |
|
| 2011 |
Cremona ML, Matthies HJ, Pau K, Bowton E, Speed N, Lute BJ, Anderson M, Sen N, Robertson SD, Vaughan RA, Rothman JE, Galli A, Javitch JA, Yamamoto A. Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT. Nature Neuroscience. 14: 469-77. PMID 21399631 DOI: 10.1038/Nn.2781 |
0.818 |
|
| 2011 |
Niswender KD, Daws LC, Avison MJ, Galli A. Insulin regulation of monoamine signaling: pathway to obesity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 359-60. PMID 21116253 DOI: 10.1038/Npp.2010.167 |
0.405 |
|
| 2011 |
Buchmayer F, Schicker K, Stübiger G, Hamilton PJ, Geier P, Jurik A, Weissensteiner R, Steinkellner T, Matthies HJ, Montgomery T, Winkler M, Yang J, Holy M, Ecker GF, Galli A, et al. Amphetamine actions rely on the availability of phosphatidylinositol-4,5-bisphosphate Bmc Pharmacology. 11: A19. DOI: 10.1186/1471-2210-11-S2-A19 |
0.649 |
|
| 2011 |
Cremona ML, Matthies HJG, Pau K, Bowton E, Speed N, Lute BJ, Anderson M, Sen N, Robertson SD, Vaughan RA, Rothman JE, Galli A, Javitch JA, Yamamoto A. Erratum: Corrigendum: Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT Nature Neuroscience. 14: 1617-1617. DOI: 10.1038/Nn1211-1617A |
0.747 |
|
| 2010 |
Speed NK, Matthies HJ, Kennedy JP, Vaughan RA, Javitch JA, Russo SJ, Lindsley CW, Niswender K, Galli A. Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression. Acs Chemical Neuroscience. 1: 476-81. PMID 22778840 DOI: 10.1021/Cn100031T |
0.833 |
|
| 2010 |
Robertson SD, Matthies HJ, Owens WA, Sathananthan V, Christianson NS, Kennedy JP, Lindsley CW, Daws LC, Galli A. Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 11305-16. PMID 20739551 DOI: 10.1523/Jneurosci.0126-10.2010 |
0.381 |
|
| 2010 |
Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP, Lindsley CW, Daws LC, Polley DB, Veenstra-Vanderweele J, Stanwood GD, Magnuson MA, Niswender KD, ... Galli A, et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. Plos Biology. 8: e1000393. PMID 20543991 DOI: 10.1371/Journal.Pbio.1000393 |
0.441 |
|
| 2010 |
Matthies HJ, Moore JL, Saunders C, Matthies DS, Lapierre LA, Goldenring JR, Blakely RD, Galli A. Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 7863-77. PMID 20534835 DOI: 10.1523/Jneurosci.4574-09.2010 |
0.645 |
|
| 2010 |
Bowton E, Saunders C, Erreger K, Sakrikar D, Matthies HJ, Sen N, Jessen T, Colbran RJ, Caron MG, Javitch JA, Blakely RD, Galli A. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 6048-57. PMID 20427663 DOI: 10.1523/Jneurosci.5094-09.2010 |
0.838 |
|
| 2010 |
Carvelli L, Matthies DS, Galli A. Molecular mechanisms of amphetamine actions in Caenorhabditis elegans. Molecular Pharmacology. 78: 151-6. PMID 20410438 DOI: 10.1124/Mol.109.062703 |
0.546 |
|
| 2009 |
Matthies HJ, Han Q, Shields A, Wright J, Moore JL, Winder DG, Galli A, Blakely RD. Subcellular localization of the antidepressant-sensitive norepinephrine transporter. Bmc Neuroscience. 10: 65. PMID 19545450 DOI: 10.1186/1471-2202-10-65 |
0.602 |
|
| 2009 |
Robertson SD, Matthies HJ, Galli A. A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Molecular Neurobiology. 39: 73-80. PMID 19199083 DOI: 10.1007/S12035-009-8053-4 |
0.556 |
|
| 2009 |
Guptaroy B, Zhang M, Bowton E, Binda F, Shi L, Weinstein H, Galli A, Javitch JA, Neubig RR, Gnegy ME. A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation. Molecular Pharmacology. 75: 514-24. PMID 19098122 DOI: 10.1124/Mol.108.048744 |
0.802 |
|
| 2008 |
Sevak RJ, Koek W, Owens WA, Galli A, Daws LC, France CP. Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats. European Journal of Pharmacology. 592: 109-15. PMID 18652823 DOI: 10.1016/J.Ejphar.2008.07.002 |
0.498 |
|
| 2008 |
Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU, Zhang M, Sen N, Colbran RJ, Gnegy ME, Gether U, Javitch JA, Erreger K, Galli A. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Molecular Pharmacology. 74: 1101-8. PMID 18617632 DOI: 10.1124/Mol.108.048447 |
0.837 |
|
| 2008 |
Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD. Anomalous dopamine release associated with a human dopamine transporter coding variant. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7040-6. PMID 18614672 DOI: 10.1523/Jneurosci.0473-08.2008 |
0.834 |
|
| 2008 |
Lute BJ, Khoshbouei H, Saunders C, Sen N, Lin RZ, Javitch JA, Galli A. PI3K signaling supports amphetamine-induced dopamine efflux. Biochemical and Biophysical Research Communications. 372: 656-61. PMID 18510945 DOI: 10.1016/J.Bbrc.2008.05.091 |
0.852 |
|
| 2008 |
Erreger K, Grewer C, Javitch JA, Galli A. Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 976-89. PMID 18216205 DOI: 10.1523/Jneurosci.2796-07.2008 |
0.772 |
|
| 2008 |
Sevak RJ, Koek W, Daws LC, Owens WA, Galli A, France CP. Behavioral effects of amphetamine in streptozotocin-treated rats. European Journal of Pharmacology. 581: 105-12. PMID 18155695 DOI: 10.1016/J.Ejphar.2007.11.047 |
0.369 |
|
| 2007 |
Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD, France CP, Gore JC, Daws LC, Avison MJ, Galli A. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. Plos Biology. 5: e274. PMID 17941718 DOI: 10.1371/Journal.Pbio.0050274 |
0.681 |
|
| 2007 |
Sevak RJ, Owens WA, Koek W, Galli A, Daws LC, France CP. Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. Journal of Neurochemistry. 101: 151-9. PMID 17217413 DOI: 10.1111/J.1471-4159.2006.04358.X |
0.465 |
|
| 2007 |
Sevak RJ, Koek W, Galli A, France CP. Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats. The Journal of Pharmacology and Experimental Therapeutics. 320: 1216-23. PMID 17170311 DOI: 10.1124/Jpet.106.115600 |
0.411 |
|
| 2007 |
Wei Y, Williams JM, Dipace C, Sung U, Javitch JA, Galli A, Saunders C. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Molecular Pharmacology. 71: 835-42. PMID 17164407 DOI: 10.1124/Mol.106.026351 |
0.53 |
|
| 2007 |
Dipace C, Sung U, Binda F, Blakely RD, Galli A. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Molecular Pharmacology. 71: 230-9. PMID 17032905 DOI: 10.1124/Mol.106.026690 |
0.653 |
|
| 2006 |
Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron. 51: 417-29. PMID 16908408 DOI: 10.1016/J.Neuron.2006.06.028 |
0.854 |
|
| 2006 |
Williams JM, Galli A. The dopamine transporter: a vigilant border control for psychostimulant action. Handbook of Experimental Pharmacology. 215-32. PMID 16722238 DOI: 10.1007/3-540-29784-7_11 |
0.598 |
|
| 2006 |
Kahlig KM, Lute BJ, Wei Y, Loland CJ, Gether U, Javitch JA, Galli A. Regulation of dopamine transporter trafficking by intracellular amphetamine. Molecular Pharmacology. 70: 542-8. PMID 16684900 DOI: 10.1124/Mol.106.023952 |
0.86 |
|
| 2006 |
Binda F, Lute BJ, Dipace C, Blakely RD, Galli A. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current. Neuropharmacology. 50: 354-61. PMID 16289633 DOI: 10.1016/J.Neuropharm.2005.09.012 |
0.8 |
|
| 2005 |
Blakely RD, Defelice LJ, Galli A. Biogenic amine neurotransmitter transporters: just when you thought you knew them. Physiology (Bethesda, Md.). 20: 225-31. PMID 16024510 DOI: 10.1152/Physiol.00013.2005 |
0.745 |
|
| 2005 |
Owens WA, Sevak RJ, Galici R, Chang X, Javors MA, Galli A, France CP, Daws LC. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. Journal of Neurochemistry. 94: 1402-10. PMID 15992364 DOI: 10.1111/J.1471-4159.2005.03289.X |
0.486 |
|
| 2005 |
Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Progress in Neurobiology. 75: 406-33. PMID 15955613 DOI: 10.1016/J.Pneurobio.2005.04.003 |
0.431 |
|
| 2005 |
Garcia BG, Wei Y, Moron JA, Lin RZ, Javitch JA, Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Molecular Pharmacology. 68: 102-9. PMID 15795321 DOI: 10.1124/Mol.104.009092 |
0.489 |
|
| 2005 |
Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proceedings of the National Academy of Sciences of the United States of America. 102: 3495-500. PMID 15728379 DOI: 10.1073/Pnas.0407737102 |
0.805 |
|
| 2004 |
Gnegy ME, Khoshbouei H, Berg KA, Javitch JA, Clarke WP, Zhang M, Galli A. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Molecular Pharmacology. 66: 137-43. PMID 15213305 DOI: 10.1124/Mol.66.1.137 |
0.748 |
|
| 2004 |
Khoshbouei H, Sen N, Guptaroy B, Johnson L', Lund D, Gnegy ME, Galli A, Javitch JA. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. Plos Biology. 2: E78. PMID 15024426 DOI: 10.1371/Journal.Pbio.0020078 |
0.759 |
|
| 2004 |
Kahlig KM, Javitch JA, Galli A. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. The Journal of Biological Chemistry. 279: 8966-75. PMID 14699142 DOI: 10.1074/Jbc.M303976200 |
0.568 |
|
| 2003 |
Kahlig KM, Galli A. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. European Journal of Pharmacology. 479: 153-8. PMID 14612146 DOI: 10.1016/J.Ejphar.2003.08.065 |
0.563 |
|
| 2003 |
Morón JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM, Lin ZC, Wang JB, Javitch JA, Galli A, Shippenberg TS. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8480-8. PMID 13679416 DOI: 10.1523/Jneurosci.23-24-08480.2003 |
0.595 |
|
| 2003 |
Sulzer D, Galli A. Dopamine transport currents are promoted from curiosity to physiology. Trends in Neurosciences. 26: 173-6. PMID 12689764 DOI: 10.1016/S0166-2236(03)00063-8 |
0.521 |
|
| 2003 |
Sung U, Apparsundaram S, Galli A, Kahlig KM, Savchenko V, Schroeter S, Quick MW, Blakely RD. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1697-709. PMID 12629174 DOI: 10.1523/Jneurosci.23-05-01697.2003 |
0.558 |
|
| 2003 |
Galici R, Galli A, Jones DJ, Sanchez TA, Saunders C, Frazer A, Gould GG, Lin RZ, France CP. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology. 77: 132-40. PMID 12624535 DOI: 10.1159/000068650 |
0.46 |
|
| 2003 |
Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. The Journal of Biological Chemistry. 278: 12070-7. PMID 12556446 DOI: 10.1074/Jbc.M212815200 |
0.776 |
|
| 2002 |
Carvelli L, Morón JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, Leeb-Lundberg LM, Merrill G, Lafer EM, Ballou LM, Shippenberg TS, Javitch JA, Lin RZ, Galli A. PI 3-kinase regulation of dopamine uptake. Journal of Neurochemistry. 81: 859-69. PMID 12065645 DOI: 10.1046/J.1471-4159.2002.00892.X |
0.6 |
|
| 2002 |
Daws LC, Callaghan PD, Morón JA, Kahlig KM, Shippenberg TS, Javitch JA, Galli A. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochemical and Biophysical Research Communications. 290: 1545-50. PMID 11820798 DOI: 10.1006/Bbrc.2002.6384 |
0.517 |
|
| 2000 |
Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proceedings of the National Academy of Sciences of the United States of America. 97: 6850-5. PMID 10823899 DOI: 10.1073/Pnas.110035297 |
0.601 |
|
| 1999 |
Galli A, Jayanthi LD, Ramsey IS, Miller JW, Fremeau RT, DeFelice LJ. L-proline and L-pipecolate induce enkephalin-sensitive currents in human embryonic kidney 293 cells transfected with the high-affinity mammalian brain L-proline transporter. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 6290-7. PMID 10414958 DOI: 10.1523/Jneurosci.19-15-06290.1999 |
0.77 |
|
| 1998 |
Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD. Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. The Journal of Pharmacology and Experimental Therapeutics. 287: 733-43. PMID 9808704 |
0.733 |
|
| 1998 |
Galli A, Blakely RD, DeFelice LJ. Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake. Proceedings of the National Academy of Sciences of the United States of America. 95: 13260-5. PMID 9789076 DOI: 10.1073/Pnas.95.22.13260 |
0.77 |
|
| 1998 |
DeFelice LJ, Galli A. Fluctuation analysis of norepinephrine and serotonin transporter currents. Methods in Enzymology. 296: 578-93. PMID 9779475 DOI: 10.1016/S0076-6879(98)96041-4 |
0.668 |
|
| 1998 |
Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biological Psychiatry. 44: 169-78. PMID 9693389 DOI: 10.1016/S0006-3223(98)00124-3 |
0.737 |
|
| 1998 |
DeFelice LJ, Galli A. Electrophysiological analysis of transporter function. Advances in Pharmacology (San Diego, Calif.). 42: 186-90. PMID 9327875 DOI: 10.1016/S1054-3589(08)60724-3 |
0.69 |
|
| 1997 |
Galli A, Petersen CI, deBlaquiere M, Blakely RD, DeFelice LJ. Drosophila serotonin transporters have voltage-dependent uptake coupled to a serotonin-gated ion channel. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 3401-11. PMID 9133366 DOI: 10.1523/Jneurosci.17-10-03401.1997 |
0.688 |
|
| 1997 |
Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 45-57. PMID 8987735 DOI: 10.1523/Jneurosci.17-01-00045.1997 |
0.713 |
|
| 1996 |
Ferroni A, Galli A, Mazzanti M. Functional role of low-voltage-activated dihydropyridine-sensitive Ca channels during the action potential in adult rat sensory neurones. PflüGers Archiv : European Journal of Physiology. 431: 954-63. PMID 8927515 DOI: 10.1007/S004240050091 |
0.52 |
|
| 1996 |
Galli A, Blakely RD, DeFelice LJ. Norepinephrine transporters have channel modes of conduction. Proceedings of the National Academy of Sciences of the United States of America. 93: 8671-6. PMID 8710929 DOI: 10.1073/Pnas.93.16.8671 |
0.705 |
|
| 1995 |
Galli A, DeFelice LJ, Duke BJ, Moore KR, Blakely RD. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. The Journal of Experimental Biology. 198: 2197-212. PMID 7500004 |
0.733 |
|
| 1994 |
Galli A, Ferroni A, Bertollini L, Mazzanti M. Inactivation of single Ca2+ channels in rat sensory neurons by extracellular Ca2+. The Journal of Physiology. 477: 15-26. PMID 8071882 DOI: 10.1113/Jphysiol.1994.Sp020167 |
0.495 |
|
| 1994 |
Galli A, DeFelice LJ. Inactivation of L-type Ca channels in embryonic chick ventricle cells: dependence on the cytoskeletal agents colchicine and taxol. Biophysical Journal. 67: 2296-304. PMID 7696470 DOI: 10.1016/S0006-3495(94)80715-5 |
0.571 |
|
| 1992 |
Mazzanti M, Galli A, Ferroni A. Effect of firing rate on the calcium permeability in adult neurons during spontaneous action potentials. Biophysical Journal. 63: 926-34. PMID 1330040 DOI: 10.1016/S0006-3495(92)81669-7 |
0.503 |
|
| Show low-probability matches. |